211 related articles for article (PubMed ID: 850091)
1. In vitro activity and clinical efficacy of clindamycin in the treatment of infections due to anaerobic bacteria.
Levison ME; Santoro J; Bran JL; Ries K; Rubin W
J Infect Dis; 1977 Mar; 135 Suppl():S49-53. PubMed ID: 850091
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of josamycin and rosamicin against Bacteroides fragilis compared with clindamycin, erythromycin, and metronidazole.
Santoro J; Kaye D; Levison ME
Antimicrob Agents Chemother; 1976 Jul; 10(1):188-90. PubMed ID: 984752
[TBL] [Abstract][Full Text] [Related]
3. Josamycin and rosamicin: in vitro comparisons with erythromycin and clindamycin.
Shadomy S; Tipple M; Paxton L
Antimicrob Agents Chemother; 1976 Oct; 10(4):773-5. PubMed ID: 984811
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of josamycin against aerobic gram-positive cocci and anaerobes.
Westerman EL; Williams TW; Moreland N
Antimicrob Agents Chemother; 1976 Jun; 9(6):988-93. PubMed ID: 7189
[TBL] [Abstract][Full Text] [Related]
5. In vitro susceptibility of common clinical anaerobic and aerobic isolates against josamycin.
Reese RE; Betts RF; Goedde LW; Douglas RG
Antimicrob Agents Chemother; 1976 Aug; 10(2):253-7. PubMed ID: 984766
[TBL] [Abstract][Full Text] [Related]
6. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
7. The susceptibility of anaerobic bacteria to rosamicin, erythromycin and clindamycin and factors affecting the activity of rosamicin.
Kwok YY; Sutter VL; Oberhammer I; Finegold SM
J Antimicrob Chemother; 1979 Jan; 5(1):61-6. PubMed ID: 33142
[No Abstract] [Full Text] [Related]
8. In-vitro activity of pristinamycin and its components against gram-negative anaerobic bacilli and Gardnerella vaginalis.
Weber P; Dubois S; Boussougant Y
J Antimicrob Chemother; 1989 Jun; 23(6):825-30. PubMed ID: 2503487
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of moxifloxacin, a new quinolone, in the treatment of experimental intra-abdominal abscesses induced by Bacteroides fragilis in mice.
Thadepalli H; Chuah SK; Gollapudi S
Chemotherapy; 2004 Jun; 50(2):76-80. PubMed ID: 15211081
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of rosamicin, josamycin, erythromycin, and clindamycin against beta-lactamase-nagative and beta-lactamase-positive strains of Neisseria gonorrhoeae.
Biddle JW; Thornsberry C
Antimicrob Agents Chemother; 1979 Feb; 15(2):243-5. PubMed ID: 106776
[TBL] [Abstract][Full Text] [Related]
11. Treatment of anaerobic bacterial infections with clindamycin-2-phosphate.
Levison ME; Bran JL; Ries K
Antimicrob Agents Chemother; 1974 Mar; 5(3):276-80. PubMed ID: 4600161
[TBL] [Abstract][Full Text] [Related]
12. Relative antibacterial efficacy of clindamycin and metronidazole against Bacteroides fragilis in vitro and in experimentally infected mice.
Dijkmans BA; Vaishnav J; Mattie H
Chemotherapy; 1985; 31(4):297-303. PubMed ID: 4028873
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of resistance and resistance transfer in anaerobic bacteria: factors influencing antimicrobial therapy.
Tally FP; Cuchural GJ; Malamy MH
Rev Infect Dis; 1984; 6 Suppl 1():S260-9. PubMed ID: 6326243
[TBL] [Abstract][Full Text] [Related]
15. Clinical characteristics and antimicrobial susceptibilities of anaerobic bacteremia in an acute care hospital.
Tan TY; Ng LS; Kwang LL; Rao S; Eng LC
Anaerobe; 2017 Feb; 43():69-74. PubMed ID: 27890724
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial therapy of anaerobic infections.
Finegold SM
Postgrad Med; 1975 Sep; 58(3):72-8. PubMed ID: 1041514
[No Abstract] [Full Text] [Related]
17. [Activity of seven antimicrobial agents against "Bacteroides fragilis" (author's transl)].
Tytgat F
Ann Microbiol (Paris); 1980; 131(1):39-44. PubMed ID: 6899739
[TBL] [Abstract][Full Text] [Related]
18. Association experiments with aerobic and anaerobic pathogens: a model of in-vitro susceptibility testing in mixed infections. Activity of enoxacin, clindamycin, and metronidazole.
Heizmann WR; Schmid R; Heilmann F; Werner H
Infection; 1989; 17(3):160-4. PubMed ID: 2737759
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of tinidazole. An in vitro comparison of the effects of tinidazole and metronidazole against Bacteroides fragilis and other Anaerobic bacteria.
Jokipii AM; Jokipii L
Chemotherapy; 1977; 23(1):25-31. PubMed ID: 318974
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of cefoperazone, cefoperazone plus sulbactam, ciprofloxacin, clindamycin, metronidazole, and penicillin G against anaerobic bacteria in an animal model.
Moody JA; Fasching CE; Sinn LM; Gerding DN; Peterson LR
J Lab Clin Med; 1990 Feb; 115(2):190-5. PubMed ID: 1967626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
